FDA Approves Newly Formulated OTC Primatene Mist (epinephrine) to Treat Mild Asthma

Print this page RANCHO CUCAMONGA, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) — Amphastar Pharmaceuticals, Inc., (NASDAQ: AMPH) announced today that the U.S. Food and Drug Administration (FDA) granted approval of its New Drug Application (NDA) for Primatene Mist (epinephrine inhalation aerosol bronchodilator suspension), which is delivered by a metered dose inhaler (MDI) with a non-chlorofluorocarbon… Read More: FDA Approves Newly Formulated OTC Primatene Mist (epinephrine) to Treat… »

Medical News Today: The connection between cirrhosis and hepatitis C

Hepatitis C and cirrhosis of the liver are medical conditions that can damage and inflame the liver. Hepatitis C is a viral illness, while cirrhosis is scarring of the liver that can occur due to hepatitis C and other medical conditions. Both conditions are individually harmful and together may make it more likely that a… Read More: Medical News Today: The connection between cirrhosis and hepatitis C »